EP1872775A1 — Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders

USPTO Abstract

A hydrophilic matrix is disclosed which comprises: a) at least one polyacrylic acid derivative in preferred amounts of 2 - 40%, b) at least one cellulose ether in preferred amounts of 30 - 90% and c) at least one disintegrant in preferred amounts of 2- 50%, with respect to the weight of the matrix. This matrix is used in combination with at least one pharmaceutically acceptable active principle for manufacturing solid bioadhesive controlled release formulations for the treatment of female genital disorders, vaginal disorders, such as vulvovaginal candidiasis , bacterial vaginosis or trichomoniasis , genital hypertrophy, genital atrophy, genital loss of elasticity, vaginal dryness. According to a preferred embodiment, the matrix is used in amounts of about 5 - 60% and the active principle in amounts of about 2- 60%, with respect to the weight of the formulation.